The effect of APO E4 on CAD severity could be the consequence of its association to significant high levels of atherogenic parameters and its association to low levels of apo E. In fact, the significant low mean concentration of apo E in CAD patients, observed also in the Italian population [10,30] suggests that apo E plays an anti-atherogenic role. The gene discussed is APOE; the disease is coronary artery disorder.